Health Diaries > Prescription Drug Watch
Merck's Cancer Drug Zolinza Approved
The FDA has approved Zolinza, Merck's first new cancer drug in about 20 years. The drug has been approved to treat cutaneous T-cell lymphoma, a rare form of non-Hodgkin's lymphoma.
While the market as a treatment for the cancer, also called CTCL, is limited, Merck is studying the drug as a tumor-fighting treatment in many other cancers, including of the breast and lung. Additional approvals from the FDA could vastly expand the market for the drug, also known as vorinostat.
Filed under Zolinza
v8j9vB
v8j9vB
Well, the post is in reality the sweetest on this worthy topic. I fit in with your conclusions and will thirstily look forward to your approaching updates. Just saying thanks will not just be adequate, for the tremendous clarity in your writing. I will directly grab your rss feed to stay informed of any updates. Good work and much success in your business enterprize!
OH crud! i just typed a nice comment and as soon as i submitted it it come up blank! Please tell me it worked properly? I do not want to sumit it again if i do not have to! Either the blog bugged out or i am just stuipd :), the latter doesnt surprise me lol.
I have MDS DX Feb 2006 RAEB. I am on 11th of Dacogen. Will Vorinostat help me?